• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断固有括约肌功能不全:比较尿道闭合压、尿道轴和瓦尔萨尔瓦漏尿点压力。

Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures.

作者信息

Bump R C, Coates K W, Cundiff G W, Harris R L, Weidner A C

机构信息

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Am J Obstet Gynecol. 1997 Aug;177(2):303-10. doi: 10.1016/s0002-9378(97)70191-1.

DOI:10.1016/s0002-9378(97)70191-1
PMID:9290444
Abstract

OBJECTIVES

Our purpose was to compare three measures proposed to diagnose intrinsic sphincteric deficiency: maximum urethral closure pressure, Valsalva leak point pressure, and straining urethral axis.

STUDY DESIGN

A total of 159 women with pure genuine stress incontinence had the three measures determined in a standardized fashion. Critical cutoff values for the Valsalva leak point pressure (52 cm) and urethral axis (22 degrees) were established by examining relative frequency distribution curves, using closure pressure of 20 as the arbitrary benchmark value for the prevalence of intrinsic sphincteric deficiency. The distribution of cutoff values is described and differences among the measures with respect to risk factors for intrinsic sphincteric deficiency and incontinence severity were determined.

RESULTS

Half the subjects fell below at least one cutoff value, but only 10% fell below all three. Sixty-four percent of subjects with either low closure pressure or leak point pressure had low values for the other, whereas 21% had discordance between them. Only 53% of subjects with low closure pressure and 40% with low leak point pressure had an axis < or = 22 degrees. Conversely, a substantial portion (36%) of subjects with pure genuine stress incontinence without urethral hypermobility had neither low urethral or leak point pressures. All three cutoff-values were associated with risk factors for intrinsic sphincteric deficiency, but only low closure and leak point pressures had significant associations with the severity of incontinence.

CONCLUSIONS

Intrinsic sphincteric deficiency should be diagnosed by a composite of historic, urodynamic, anatomic, and clinical severity criteria. We would include a maximum urethral closure pressure < or = 20, a Valsalva leak point pressure < or = 50, and a stress urethral axis < or = 20 in this composite.

摘要

目的

我们的目的是比较三种用于诊断固有括约肌功能不全的指标:最大尿道闭合压、瓦尔萨尔瓦漏尿点压和用力时尿道轴。

研究设计

总共159名单纯性真性压力性尿失禁女性以标准化方式测定了这三种指标。通过检查相对频率分布曲线,以20作为固有括约肌功能不全患病率的任意基准值,确定了瓦尔萨尔瓦漏尿点压(52厘米)和尿道轴(22度)的临界截断值。描述了截断值的分布,并确定了这些指标在固有括约肌功能不全的危险因素和尿失禁严重程度方面的差异。

结果

一半的受试者至少低于一个截断值,但只有10%的受试者低于所有三个截断值。64%的最大尿道闭合压或漏尿点压低的受试者另一个指标值也低,而21%的受试者两者不一致。最大尿道闭合压低的受试者中只有53%、漏尿点压低的受试者中只有40%的尿道轴≤22度。相反,相当一部分(36%)无尿道活动过度的单纯性真性压力性尿失禁受试者既没有低尿道压也没有低漏尿点压。所有三个截断值都与固有括约肌功能不全的危险因素相关,但只有低闭合压和低漏尿点压与尿失禁严重程度有显著关联。

结论

固有括约肌功能不全应通过病史、尿动力学、解剖学和临床严重程度标准的综合来诊断。我们建议该综合标准包括最大尿道闭合压≤20、瓦尔萨尔瓦漏尿点压≤50和应力性尿道轴≤20。

相似文献

1
Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures.诊断固有括约肌功能不全:比较尿道闭合压、尿道轴和瓦尔萨尔瓦漏尿点压力。
Am J Obstet Gynecol. 1997 Aug;177(2):303-10. doi: 10.1016/s0002-9378(97)70191-1.
2
The effect of vesical volume on Valsalva leak-point pressures in women with genuine stress urinary incontinence.膀胱容量对真性压力性尿失禁女性瓦尔萨尔瓦漏尿点压力的影响。
Obstet Gynecol. 1996 May;87(5 Pt 1):711-4. doi: 10.1016/0029-7844(96)00018-x.
3
Correlation of urodynamic measures of urethral resistance with clinical measures of incontinence severity in women with pure genuine stress incontinence. The Continence Program for Women Research Group.单纯性真性压力性尿失禁女性尿道阻力的尿动力学测量与尿失禁严重程度临床测量的相关性。女性控尿项目研究组。
Am J Obstet Gynecol. 1995 Aug;173(2):407-12; discussion 412-4. doi: 10.1016/0002-9378(95)90260-0.
4
Valsalva leak point pressures in women with genuine stress incontinence: reproducibility, effect of catheter caliber, and correlations with other measures of urethral resistance. Continence Program for Women Research Group.真性压力性尿失禁女性的瓦尔萨尔瓦漏点压:可重复性、导管管径的影响以及与其他尿道阻力测量指标的相关性。女性尿失禁研究小组。
Am J Obstet Gynecol. 1995 Aug;173(2):551-7. doi: 10.1016/0002-9378(95)90281-3.
5
[Valsalva minimal leak point pressure: a useful approximation to type III female urinary incontinence].[瓦尔萨尔瓦最小漏点压:Ⅲ型女性尿失禁的有效近似值]
Arch Esp Urol. 1998 Oct;51(8):783-9.
6
Urethral closure pressure and leak-point pressure in incontinent women.尿失禁女性的尿道闭合压和漏尿点压力
Obstet Gynecol. 1995 Nov;86(5):839-42. doi: 10.1016/0029-7844(95)00263-Q.
7
Correlation of Valsalva leak point pressure with subjective degree of stress urinary incontinence in women.女性瓦尔萨尔瓦漏尿点压力与压力性尿失禁主观程度的相关性
J Urol. 1996 Jan;155(1):281-5.
8
[Correlation of maximum urethral closure pressure and Valsalva leak-point pressure in patients with genuine stress incontinence].[真性压力性尿失禁患者最大尿道闭合压与valsalva漏尿点压力的相关性]
Ceska Gynekol. 2004 Jul;69(4):267-72.
9
Preoperative Urodynamic Parameters (Valsalva Leak Point Pressure and Maximum Urethral Closure Pressure), Urinary Collagen and Plasma Vitamin D Levels as Predictors of Mid Urethral Sling Surgery Outcome.术前尿动力学参数(Valsalva 漏尿点压力和最大尿道闭合压)、尿胶原蛋白和血浆维生素 D 水平作为尿道中段吊带手术结局的预测指标。
J Urol. 2016 Sep;196(3):819-23. doi: 10.1016/j.juro.2016.03.177. Epub 2016 Apr 23.
10
Clinical and demographic factors associated with valsalva leak point pressure among women undergoing burch bladder neck suspension or autologous rectus fascial sling procedures.接受伯奇膀胱颈悬吊术或自体腹直肌筋膜吊带手术的女性中与瓦尔萨尔瓦漏点压相关的临床和人口统计学因素。
Neurourol Urodyn. 2007;26(3):392-6. doi: 10.1002/nau.20325.

引用本文的文献

1
The Placement of a Single-Incision Mini-Sling for the Treatment of Complete Intrinsic Sphincter Deficiency in an Adolescent Female: A Case Report.单切口迷你吊带置入术治疗青春期女性完全性固有括约肌缺陷:一例报告
HCA Healthc J Med. 2024 Aug 1;5(4):465-467. doi: 10.36518/2689-0216.1672. eCollection 2024.
2
Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study.经阴道激光治疗失败后女性压力性尿失禁行尿道内铒激光治疗的疗效和安全性:一项回顾性研究。
Lasers Med Sci. 2023 Sep 9;38(1):207. doi: 10.1007/s10103-023-03872-5.
3
Anal canal to pubis angle: a novel clinical ultrasound technique for the assessment of the anorectal region.
肛管至耻骨夹角:一种评估肛肠区域的新型临床超声技术。
Int Urogynecol J. 2021 Sep;32(9):2421-2427. doi: 10.1007/s00192-021-04855-2. Epub 2021 Jul 8.
4
Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.尿道内铒激光治疗绝经后泌尿生殖综合征的泌尿症状:一项初步研究。
Lasers Surg Med. 2018 Oct;50(8):802-807. doi: 10.1002/lsm.22826. Epub 2018 Apr 18.
5
Anterior vaginal repair for urinary incontinence in women.女性尿失禁的阴道前壁修补术
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD001755. doi: 10.1002/14651858.CD001755.pub2.
6
Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency).非剥脱性铒钇铝石榴石激光治疗Ⅲ型压力性尿失禁(固有括约肌缺陷)。
Lasers Med Sci. 2017 Apr;32(3):685-691. doi: 10.1007/s10103-017-2170-5. Epub 2017 Feb 16.
7
Maximum urethral closure pressure in women: normative data and evaluation as a diagnostic test.女性最大尿道闭合压:正常数据及作为诊断测试的评估
Int Urogynecol J. 2012 Nov;23(11):1613-8. doi: 10.1007/s00192-012-1770-7. Epub 2012 May 15.
8
Do urodynamic parameters predict persistent postoperative stress incontinence after midurethral sling? A systematic review.尿动力学参数能否预测经尿道中段吊带术后持续性压力性尿失禁?一项系统评价。
Int Urogynecol J. 2012 Jul;23(7):813-22. doi: 10.1007/s00192-012-1693-3. Epub 2012 Mar 9.
9
Clinical factors associated with low valsalva leak point pressure among women with stress urinary incontinence.与压力性尿失禁女性的低valsalva 漏点压相关的临床因素。
Int Neurourol J. 2011 Dec;15(4):211-5. doi: 10.5213/inj.2011.15.4.211. Epub 2011 Dec 31.
10
Where should bulking agents for female urodynamic stress incontinence be injected?女性压力性尿失禁填充剂应注射在何处?
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Dec;19(12):1723-4. doi: 10.1007/s00192-008-0625-8. Epub 2008 Apr 24.